[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 16, Issue 1 (Summer 2020) ::
Sci J Iran Blood Transfus Organ 2020, 16(1): 24-31 Back to browse issues page
Evaluation of alternations in the expression of CCR5 chemokine receptor in acute myeloid leukemia patients with monocytic differentiation after chemotherapy
Z. Yazdani, Z. Mousavi, N. Ghasemi mehr, A. Fatemi Dr., A.R. Farsinezhad Dr., Gh.H. Hassan Shahi Dr.
Abstract:   (807 Views)
Abstract
Background and Objectives
Acute myeloid leukemia (AML) is a heterogeneous cancer that is caused by various pathologic mechanisms. Cancer cells change the chemokine system. CCR5 receptor has an indirect effect on cancer progression by controlling immune response against the tumor. This receptor can accelerate tumor growth and play a significant role in tumor metastasis, and it has been shown that CCR5 antagonists inhibit tumor growth. In this study, we decided to investigate the CCR5 receptor in AML patients after the first stage chemotherapy.
 
Materials and Methods
This case-control study was conducted in Kerman University of Medical Sciences during 2017-2018. Twenty five AML patients with monocytic differentiation post the first stage of chemotherapy (the fourth week after chemotherapy), after being examined for the peripheral blood smear and confirmed for the absence of blast cells, were evaluated by flow cytometry for the expression of the CCR5 receptor on the peripheral blood leukocytes population and were compared with healthy controls. The data were analyzed by independent T-Test and SPSS (version 22).
 
Results
The results of this study showed that the mean expression of CCR-5 in the patients group post-chemotherapy (1.04 ± 0.26) was similar with the healthy control group (1.04 ± 0.16).  Moreover, there was no meaningful difference between the two groups.
 
Conclusions  
Chemotherapy has caused the CCR5 receptor expression to be in its base state compared to the healthy control group. Other chemokine syndromes and their receptors could be examined to find out which role would play a significant role in the recurrence of patients.
 


Keywords: Key words: Acute Myeloid Leukemia, Chemotherapy, Monocytes, Tumors
Full-Text [PDF 551 kb]   (154 Downloads) |   |   Full-Text (HTML)  (141 Views)  
Type of Study: Research | Subject: Hematology
Published: 2019/04/8
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Yazdani Z, Mousavi Z, Ghasemi mehr N, Fatemi A, Farsinezhad A, Hassan Shahi G. Evaluation of alternations in the expression of CCR5 chemokine receptor in acute myeloid leukemia patients with monocytic differentiation after chemotherapy. Sci J Iran Blood Transfus Organ. 2020; 16 (1) :24-31
URL: http://bloodjournal.ir/article-1-1217-en.html


Volume 16, Issue 1 (Summer 2020) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.06 seconds with 33 queries by YEKTAWEB 3977